Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News Alteril : Exploring the natural solution for enhanced sleep quality In today’s fast-paced world, the quest for a good night’s sleep has become increasingly challenging for many. Alteril… bypharmanewsdailyJune 1, 2024